1. Home
  2. ATLC vs MPLT Comparison

ATLC vs MPLT Comparison

Compare ATLC & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlanticus Holdings Corporation

ATLC

Atlanticus Holdings Corporation

N/A

Current Price

$92.98

Market Cap

1.7B

Sector

Finance

ML Signal

N/A

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

N/A

Current Price

$8.84

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ATLC
MPLT
Founded
1996
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2009
2025

Fundamental Metrics

Financial Performance
Metric
ATLC
MPLT
Price
$92.98
$8.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
15
Target Price
★ $130.60
$26.54
AVG Volume (30 Days)
89.0K
★ 362.2K
Earning Date
11-09-2026
08-13-2026
Dividend Yield
N/A
N/A
EPS Growth
24.95
★ 82.39
EPS
★ 4.74
N/A
Revenue
★ $1,968,399,000.00
N/A
Revenue This Year
$443.34
N/A
Revenue Next Year
$14.01
N/A
P/E Ratio
$19.36
★ N/A
Revenue Growth
★ 50.09
N/A
52 Week Low
$47.50
$8.92
52 Week High
$114.34
$40.43

Technical Indicators

Market Signals
Indicator
ATLC
MPLT
Relative Strength Index (RSI) 51.54 26.17
Support Level $91.00 N/A
Resistance Level $95.69 $14.22
Average True Range (ATR) 3.12 0.61
MACD 0.55 0.02
Stochastic Oscillator 80.60 0.00

Price Performance

Historical Comparison
ATLC
MPLT

About ATLC Atlanticus Holdings Corporation

Atlanticus Holdings Corp is a financial technology company powering more inclusive financial solutions for Everyday Americans. It provides technology and other support services to lenders who offer an array of financial products and services to consumers. The company's products and services are reported through two reportable segments. Credit as a Service (CaaS) offers products including private label credit cards using the Fortiva and Curae brand names as well as merchant-associated brands and Auto Finance provides purchase and/or service loans secured by automobiles from or for, and also provides floor-plan financing for, a pre-qualified network of independent automotive dealers and automotive finance companies in the buy-here, pay-here used car business.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: